Mephenytoin

美芬妥英

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMephenytoin
Drug Alias Name3-甲基苯乙妥因Methoin甲基苯乙妥因Phenantoin美芬妥因 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsSeizuresEpilepsy
Global Approved IndicationsSeizuresEpilepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1946/10/23
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsSeizuresEpilepsy

Other Information

ATC CodeN03AB04
Related LinksWikipediaDrugBankKEGG